Toker recognized for ‘seminal contributions’ to lipid biology
always has been interested in science, and he recalls many days spent at the Natural History Museum in London, where he grew up. Yet it wasn’t until his postdoctoral years spent under the mentorship of that he decided to make research his career.

“I just had kind of an epiphany and decided this is what I want to do for the rest of my life,” Toker said. “I loved basic science and discovering things.”
In 1988, Cantley won the 91Ӱ and Molecular Biology’s Avanti Award in Lipids. Toker, now a professor at Harvard Medical School and editor-in-chief of the Journal of Biological Chemistry, will receive the same award in 2022. Toker is being recognized for his work on lipid signaling and particularly his studies on phosphatidylinositol 3-OH kinase, or PI3K, and serine/threonine kinase AKT signaling in cancer.
, a distinguished professor and chair in chemistry at Texas A&M University and winner of the 2019 Avanti Award, wrote in his nomination letter that Toker deserved the award for his “seminal contributions to the lipid field” and “steadfast professionalism.” Toker received word about the award while on vacation in New Hampshire.
“I was just so proud and ecstatic and filled with a sense of achievement and recognition by my peers,” Toker said. “It really is a culmination of 20-plus years of running a laboratory, and, considering the past recipients, it is truly humbling.”
The discovery aspect of research still drives him, and he enjoys the independence and creativity scientific research can bring. He is also passionate about mentoring.
“The greatest source of joy and pride and the most satisfying aspect of my career is really the training of the scientists and students that I’ve had in my laboratory,” he said.
Toker credits his family, trainees, mentors and colleagues with helping get to where he is today.
Pathways past and future
Alex Toker’s research focuses on understanding how intracellular signaling pathways affect cancer cell behavior. During his postdoc work, he identified that a protein kinase called Akt, also known as protein kinase B, or PKB, was activated by lipid products of the PI3K pathway, thus linking the two signaling pathways.
The two pathways, together with the mammalian target of rapamycin, or mTOR, pathway, collectively control cellular metabolism, proliferation and growth, and survival. All are dysregulated in certain types of cancer.
In his award talk, Toker plans to start at his seminal discovery linking lipid mediators with specific signaling and move through his subsequent work characterizing Akt and other pathways in the cell and in cancer. He also will focus on where he thinks the field is going and ongoing studies in his lab aimed at designing therapeutic interventions targeting the pathway.
2022 91Ӱaward winners
Lea Michel, 91ӰEarly Career Leadership Award
Marlene Belfort, 91ӰMid-Career Leadership Award
Michael Airola, Walter A. Shaw Young Investigator Award in Lipid Research
Tatyana Sharpee, Delano Award for Computational Biosciences
Tracy Johnson, Ruth Kisrchstein Diversity in Science Award
Martin Bollinger, William C. Rose Award
Joe Provost, 91ӰAward for Exemplary Contributions to Education
Walther and Robert Farese Jr., ASBMB–Merck Award
Greg Wang, 91ӰYoung Investigator Award
Janet Smith, Mildred Cohn Award
Kathleen Collins, Earl and Thressa Stadtman Distinguished Scientist Award
Elaine Fuchs, Bert and Natalie Vallee Award in Biomedical Science
Susan Taylor, Herbert Tabor Research Award
John Boothroyd, Alice and C.C. Wang Award in Molecular Parasitology
Enjoy reading 91ӰToday?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91ӰToday
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

91Ӱmembers recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, 91Ӱeducators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

91Ӱundergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.